Univariable and multivariable regression analyses of clinicopathological characteristics and traditional MRI features revealed that Ki67 quantification was the only independent predictor of tumor shrinkage patterns after NAC in HR+/HER2- breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.